ID: ALA4751417

Max Phase: Preclinical

Molecular Formula: C37H40N2O8

Molecular Weight: 640.73

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc2cc1Oc1ccc(cc1)C[C@H]1c3cc(c(OC)cc3CCN1OC)Oc1c(O)c(OC)cc3c1[C@H](C2)N(OC)CC3

Standard InChI:  InChI=1S/C37H40N2O8/c1-41-30-11-8-23-17-29-35-25(13-15-39(29)45-5)20-34(43-3)36(40)37(35)47-33-21-27-24(19-31(33)42-2)12-14-38(44-4)28(27)16-22-6-9-26(10-7-22)46-32(30)18-23/h6-11,18-21,28-29,40H,12-17H2,1-5H3/t28-,29-/m0/s1

Standard InChI Key:  YXVGNQHDPPKIQH-VMPREFPWSA-N

Associated Targets(Human)

MRC5 9203 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Human coronavirus OC43 66 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 640.73Molecular Weight (Monoisotopic): 640.2785AlogP: 6.72#Rotatable Bonds: 5
Polar Surface Area: 91.32Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.19CX Basic pKa: 1.29CX LogP: 5.56CX LogD: 5.55
Aromatic Rings: 4Heavy Atoms: 47QED Weighted: 0.25Np Likeness Score: 1.55

References

1. Choudhry N,Zhao X,Xu D,Zanin M,Chen W,Yang Z,Chen J.  (2020)  Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).,  63  (22.0): [PMID:32845145] [10.1021/acs.jmedchem.0c00626]

Source